Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection Presented at the 11th Congress of the European-African Hepato-Pancreato-Biliary Association, Manchester, UK, April 2015.

Journal of the American College of Surgeons

Volumn 221, Issue 6, 2015, Pages 1041-1049

  Groot Koerkamp, Bas ^a,c   Wiggers, Jimme K ^b   Allen, Peter J ^a   Besselink, Marc G ^b   Blumgart, Leslie H ^a   Busch, Olivier R C ^b   Coelen, Robert J ^b   D'Angelica, Michael I ^a   DeMatteo, Ronald P ^a   Gouma, Dirk J ^b   Kingham, T Peter ^a   Jarnagin, William R ^a   Van Gulik, Thomas M ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; AGED; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CONFERENCE PAPER; FEMALE; HEPATOJEJUNOSTOMY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PERIHILAR CHOLANGIOCARCINOMA; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; TUMOR DIFFERENTIATION; BILE DUCT NEOPLASMS; CANCER STAGING; COHORT ANALYSIS; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; JEJUNOSTOMY; KLATSKIN TUMOR; LIVER RESECTION; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; SECONDARY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BILE DUCT NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; JEJUNOSTOMY; KLATSKIN TUMOR; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; TREATMENT OUTCOME;

EID: 84951094583     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.09.005     Document Type: Conference Paper

References (29)

1. S.B. Edge AJCC Cancer Staging Manual 7th edition 2010 Springer New York, USA
2. W.R. Jarnagin, Y. Fong, R.P. DeMatteo, and et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 2001 507 517 discussion 517-519
3. I. Popescu, and T. Dumitrascu Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making Langenbeck's Arch Surg / Deutsche Gesellschaft fur Chirurgie 399 2014 693 705
4. X.P. Chen, W.Y. Lau, Z.Y. Huang, and et al. Extent of liver resection for hilar cholangiocarcinoma Br J Surg 96 2009 1167 1175
5. T. Dumitrascu, D. Chirita, M. Ionescu, and I. Popescu Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome J Gastrointest Surg 17 2013 913 924
6. G. Nuzzo, F. Giuliante, F. Ardito, and et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients Arch Surg 147 2012 26 34
7. M.A. Wahab, A.M. Sultan, T. Salah, and et al. Caudate lobe resection with major hepatectomy for central cholangiocarcinoma: is it of value? Hepatogastroenterology 59 2012 321 324
8. W.R. Jarnagin, L. Ruo, S.A. Little, and et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies Cancer 98 2003 1689 1700
9. A. Kobayashi, S. Miwa, T. Nakata, and S. Miyagawa Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma Br J Surg 97 2010 56 64
10. M.F. Gerhards, D.G. Gonzalez, H. ten Hoopen-Neumann, and et al. Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy Eur J Surg Oncol 26 2000 480 485
11. K. Matsuo, F.G. Rocha, K. Ito, and et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients J Am Coll Surg 215 2012 343 355
12. T.M. van Gulik, J.J. Kloek, A.T. Ruys, and et al. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival Eur J Surg Oncol 37 2011 65 71
13. National Comprehensive Cancer Network. Hepatobiliary Cancers. Available at: http://www.nccn.org/professionals/physician-gls/pdf/hepatobiliary.pdf. Accessed August 1, 2015.
14. N. Furusawa, A. Kobayashi, T. Yokoyama, and et al. Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality World J Surg 38 2014 1164 1176
15. J. Klempnauer, G.J. Ridder, R. von Wasielewski, and et al. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors J Clin Oncol 15 1997 947 954
16. S.G. Lee, G.W. Song, S. Hwang, and et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience J Hepato-Biliary-Pancreatic Sci 17 2010 476 489
17. S.C. Song, D.W. Choi, A.W. Kow, and et al. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre ANZ J Surg 83 2013 268 274
18. I. Endo, M.G. House, D.S. Klimstra, and et al. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma Ann Surg Oncol 15 2008 2104 2112
19. T. Aoba, T. Ebata, Y. Yokoyama, and et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes Ann Surg 257 2013 718 725
20. A. Guglielmi, A. Ruzzenente, T. Campagnaro, and et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma J Gastrointest Surg 17 2013 1917 1928
21. J. Valle, H. Wasan, D.H. Palmer, and et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 2010 1273 1281
22. J.W. Valle, J. Furuse, M. Jitlal, and et al. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials Ann Oncol 25 2014 391 398
23. P. Neuhaus, A. Thelen, S. Jonas, and et al. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma Ann Surg Oncol 19 2012 1602 1608
24. Y. Kaneoka, A. Yamaguchi, M. Isogai, and T. Kumada Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy World J Surg 34 2010 2662 3670
25. S. Darwish Murad, W.R. Kim, D.M. Harnois, and et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers Gastroenterology 143 2012 88 98.e3 quiz e14
26. A.T. Ruys, B.E. van Beem, M.R. Engelbrecht, and et al. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis Br J Radiol 85 2012 1255 1262
27. G.M. Kaiser, A. Paul, G. Sgourakis, and et al. Novel prognostic scoring system after surgery for Klatskin tumor Am Surg 79 2013 90 95
28. O. Farges, J.M. Regimbeau, D. Fuks, and et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma Br J Surg 100 2013 274 283
29. K. Ito, H. Ito, P.J. Allen, and et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma Ann Surg 251 2010 675 681